Alphatec Holdings, Inc.
|
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
(Title of Class of Securities)
|
02081G102
|
(CUSIP Number)
|
Jeffrey Wade
c/o LS Power Development, LLC
1700 Broadway, 35th Floor
New York, New York 10019
212-547-2914
With a copy to:
Adam M. Turteltaub
Jonathan Kubek
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
212-728-8129
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications) |
January 25, 2023
|
(Date of Event which Requires Filing of this Statement)
|
|
||||||
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) L-5 Healthcare Partners, LLC
|
|||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
|||||
3
|
SEC USE ONLY
|
|||||
4
|
SOURCE OF FUNDS
WC
|
|||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
|
|||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||||
8
|
SHARED VOTING POWER
13,343,865(1)
|
|||||
9
|
SOLE DISPOSITIVE POWER
0
|
|||||
10
|
SHARED DISPOSITIVE POWER
13,343,865 (1)
|
|||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,343,865
|
|||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
☐
|
|||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.42% (2)
|
|||||
14
|
TYPE OF REPORTING PERSON
OO
|
|||||
(1) Represents 10,997,833 shares of Common Stock held by L-5 Healthcare Partners, LLC, plus 2,346,032 shares of Common Stock issuable upon exercise of warrants to purchase shares of
Common Stock at an exercise price of $3.50 per share (the “Warrants”), held by L-5 Healthcare Partners, LLC.
(2) Calculation is based upon (i) 105,058,324 shares of Common Stock outstanding as reported in the Issuer’s Form 10-Q filed on November 3, 2022, plus (ii) the shares of Common Stock
issuable upon exercise of the Warrants.
|
|
|||
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Paul Segal
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☐
|
||
3
|
SEC USE ONLY
|
||
4
|
SOURCE OF FUNDS
OO
|
||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
☐
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
338,825
|
|
8
|
SHARED VOTING POWER
13,343,865 (1)
|
||
9
|
SOLE DISPOSITIVE POWER
338,825
|
||
10
|
SHARED DISPOSITIVE POWER
13,343,865 (1)
|
||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,682,690
|
||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
☐
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
12.74% (2)
|
||
14
|
TYPE OF REPORTING PERSON
IN
|
||
(1) Represents 10,997,833 shares of Common Stock held by L-5 Healthcare Partners, LLC, plus 2,346,032 shares of Common Stock issuable upon exercise of warrants to purchase shares of Common Stock at an exercise price of $3.50 per share
(the “Warrants”), held by L-5 Healthcare Partners, LLC.
(2) Calculation is based upon (i) 105,058,324 shares of Common Stock outstanding as reported in the Issuer’s Form 10-Q filed on November 3, 2022, plus (ii) the shares of Common Stock issuable upon exercise of the Warrants.
|
|||
By: /s/ Paul Segal
Name: Paul Segal
Title: President |
|